AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (346.5 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Perspective | Open Access

Antibody-drug conjugates in breast cancer: advances and prospects

Zhiqiang Shi1,2,*Yongjin Lu1,3,*Qiuchen Zhao4Yongsheng Wang1Pengfei Qiu1 ( )
Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China
Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin 300202, China
Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan 271016, China
Cancer Research UK Cambridge Centre PhD Programme, University of Cambridge, Cambridge CB2 0XZ, UK

*These authors contributed equally to this work.

Show Author Information

References

【1】
【1】
 
 
Cancer Biology & Medicine
Pages 83-92

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Shi Z, Lu Y, Zhao Q, et al. Antibody-drug conjugates in breast cancer: advances and prospects. Cancer Biology & Medicine, 2025, 22(2): 83-92. https://doi.org/10.20892/j.issn.2095-3941.2024.0486

567

Views

66

Downloads

3

Crossref

4

Web of Science

5

Scopus

Received: 01 November 2024
Accepted: 17 January 2025
Published: 17 February 2025
©2025 The Authors.

Creative Commons Attribution-NonCommercial 4.0 International License